RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 131 filers reported holding RELAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 13.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,806,258 | -19.9% | 214,775 | +19.6% | 0.00% | – |
| Q2 2023 | $2,254,733 | -63.8% | 179,517 | -52.6% | 0.00% | -100.0% |
| Q1 2023 | $6,237,140 | +454.3% | 378,697 | +402.8% | 0.00% | – |
| Q4 2022 | $1,125,206 | -80.1% | 75,315 | -70.2% | 0.00% | -100.0% |
| Q3 2022 | $5,658,000 | +85.4% | 252,953 | +38.9% | 0.00% | – |
| Q2 2022 | $3,051,000 | -22.3% | 182,137 | +38.8% | 0.00% | – |
| Q1 2022 | $3,927,000 | -67.3% | 131,180 | -66.4% | 0.00% | – |
| Q4 2021 | $12,008,000 | +238.1% | 390,988 | +247.0% | 0.00% | – |
| Q3 2021 | $3,552,000 | +177.1% | 112,666 | +221.6% | 0.00% | – |
| Q2 2021 | $1,282,000 | -55.3% | 35,033 | -57.8% | 0.00% | – |
| Q1 2021 | $2,869,000 | +193.4% | 82,999 | +252.6% | 0.00% | – |
| Q4 2020 | $978,000 | – | 23,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |